IQVIA sits at the center of the pharmaceutical industry’s information flow. It collects and sells data on prescriptions, healthcare utilization, and patient activity from a large number of sources, which companies use to understand markets, size opportunities, and plan commercial strategy. The company is also a major contract research organization that runs clinical trials, recruiting patients, managing sites, and handling data on behalf of drug developers.
Technology and AI are applied to both lines of business. Analytics platforms combine data sets to deliver insights to sales and marketing teams, and AI helps identify suitable trial sites and patients, predict enrollment, and automate documentation and safety reporting. IQVIA has been building AI agents for tasks such as data analysis and trial operations, often in partnership with large technology companies.
IQVIA sells to pharmaceutical, biotech, and healthcare organizations on custom contracts. It is a large public company, and its data practices have drawn attention from privacy advocates, although it states that data is de-identified. Competitors include Veeva, ICON, Parexel, Syneos Health, Medidata for trial technology, and Komodo Health for data. IQVIA is relevant mainly to life sciences companies.